Background
The prognostic value of the six-minute walk test (6MWT) in patients with stable coronary heart disease (CHD) is unknown. We sought to determine whether the 6MWT predicted cardiovascular events in ambulatory patients with CHD.
Methods
We measured 6MWT distance and treadmill exercise capacity in 556 outpatients with stable CHD between September 2000 and December 2002. Participants were followed for a median of 8.0 years for cardiovascular events (heart failure, myocardial infarction, and death).
Results
Cardiovascular events occurred in 39% (218/556) of participants. Patients in the lowest quartile of 6MWT distance (87–419 meters) had 4 times the rate of events as those in the highest quartile (544–837 meters) (unadjusted HR 4.29, 95%CI 2.83–6.53, p<0.0001). Each standard deviation (SD) decrease in 6MWT distance (104 meters) was associated with a 55% higher rate of cardiovascular events (age-adjusted HR 1.55, 95%CI 1.35–1.78). After adjustment for traditional risk factors and cardiac disease severity measures (ejection fraction, inducible ischemia, diastolic dysfunction, NT-proBNP, and CRP), each SD decrease in 6MWT was associated with a 30% higher rate of cardiovascular events (HR 1.30, 95%CI 1.10–1.53). When added to traditional risk factors, the 6MWT resulted in category-free net reclassification improvement of 39% (95%CI 19%–60%). The discriminative ability of 6MWT was similar to treadmill exercise capacity for predicting cardiovascular events (c-statistics both 0.72, p =0.29).
Conclusions
Distance walked on 6MWT predicted cardiovascular events in patients with stable CHD. The addition of a simple 6MWT to traditional risk factors improved risk prediction and was comparable to treadmill exercise capacity.